pubrio
Medicalgorithmics S.A. logo

Medicalgorithmics S.A.

Public
medicalgorithmics.com
软件开发200+ employeesFounded 2005🇵🇱 波兰

Medicalgorithmics is a medical technology company specialized in AI-powered and noninvasive solutions for cardiac arrhythmia. Over the past 15 years, we have transformed into a global provider of cutting-edge solutions that help improve the health of patients around the world. We have put science and innovation at the heart of our work. We are closely cooperating with healthcare professionals to reduce costs, streamline clinical workflows and most importantly improve the quality of patient care. We are striving to design AI algorithms that can accurately detect and diagnose diseases at an early stage, increasing the chances of a successful treatment. Our innovative portfolio spans across software, artificial intelligence and cloud based solutions for healthcare systems, physicians and medical technology companies. Our flagship products include PocketECG system, FDA-approved TechBot and DeepRhythm software platforms for cardiac arrhythmia. We invented noninvasive AI-powered VCAST (Virtual Cardiac Stress Test) technology, which we believe can revolutionize the diagnosis and treatment of coronary artery disease in the years ahead. Medicalgorithmics has been listed on the Warsaw Stock Exchange since 2014.

成立年份
2005
员工人数
200+
行业
软件开发
公司类型
Public Company
总部
🇵🇱Warszawa, - (+2)
专长
信息技术与服务医疗器械软件开发医疗保健人工智能

扩张情报

全新 · 仅在 Pubrio

我们正在追踪 Medicalgorithmics S.A. 的市场扩张

全球扩张

实时
阶段
探索中投入中进入中运营中

活动脉搏

新增 营销与公关 活动 — 刚出现 34 个新信号。

最近 90 天
招聘
0
无活动
营销与公关
34新增
广告投放
产品与技术
0
无活动
+2个类别已锁定
已显示 5 个中的 3 个
了解一下

关于 Medicalgorithmics S.A. 的常见问题

关于 Medicalgorithmics S.A. 的业务、市场和增长信号的快速解答。

Medicalgorithmics is a medical technology company specialized in AI-powered and noninvasive solutions for cardiac arrhythmia. Over the past 15 years, we have transformed into a global provider of cutting-edge solutions that help improve the health of patients around the world. We have put science and innovation at the heart of our work. We are closely cooperating with healthcare professionals to reduce costs, streamline clinical workflows and most importantly improve the quality of patient care. We are striving to design AI algorithms that can accurately detect and diagnose diseases at an early stage, increasing the chances of a successful treatment. Our innovative portfolio spans across software, artificial intelligence and cloud based solutions for healthcare systems, physicians and medical technology companies. Our flagship products include PocketECG system, FDA-approved TechBot and DeepRhythm software platforms for cardiac arrhythmia. We invented noninvasive AI-powered VCAST (Virtual Cardiac Stress Test) technology, which we believe can revolutionize the diagnosis and treatment of coronary artery disease in the years ahead. Medicalgorithmics has been listed on the Warsaw Stock Exchange since 2014.

今天就开启旅程

可以先用平台,也可以先聊聊

你可以自行使用 Pubrio,或让我们的团队协助研究、获客或数据整合。

与团队沟通
Start Journey Image
pubrio

Pubrio 将来自 50+ 本地来源的商业、人物与意向数据整合为全球图谱,帮助 AI 与营收团队洞悉全市场。

© 2026 Pubrio。保留所有权利。